Hormone Therapy

The FDA approved relugolix for the treatment of men with advanced prostate cancer.

The FDA granted tentative approval to oral testosterone for testosterone replacement therapy in men with conditions associated with a deficiency or absence of endogenous testosterone, according to an industry press release.

Pretreatment differences in athletic performance for transgender women in the U.S. Air Force vs. cisgender women continue more than 1 year after startingfeminizing therapy, according to findings published in the British Journal of Sports Medicine.

A randomized clinical trial that showed multiple benefits to a plant-based vegan diet was the top story in endocrinology last week.

During the menopausal transition, women have an increased prevalence of cardiometabolic and CV risk factors; however, data on early preventive strategies are lacking, according to a new statement from the American Heart Association.

October is World Menopause Month. Healio and Endocrine Today have compiled a list of the most read recent news about menopause.

The content, style and elements of consent forms for pubertal suppression and gender-affirming hormone therapies vary greatly, according to research presented at this year’s virtual Women in Medicine Summit.

Brain effects of menopausal hormone therapy differ based on the route of delivery, according to a recent study. It was the top story in endocrinology last week.

Common antibiotic drugs — even those that do not induce enzymes — may reduce the effectiveness of hormonal contraceptives and lead to unintended pregnancy, according to study data published in BMJ Evidence-Based Medicine.

Early menopausal women experienced different changes in cognitive health imaging biomarkers based on route of delivery of hormone therapy vs. placebo in the Kronos Early Estrogen Prevention Study, according to a speaker.